Your optimism is commendable Joe. I do hope you are right on all...

Your optimism is commendable Joe.
I do hope you are right on all fronts.

Reading through latest corporate presentation and particularly catalyst's this year. The primary one stated is P2b HNSCC 'top line read out end of year' (50% recruited thus far). I'm sure there will be other announcements during the year but the 'catalyst' is end of 2023. Assumption being the catalyst read out will 'a person or thing the precipitates an event'.

Let's hope the event is a major re-rating of SP or a major announcement that would also have a SP re-rating - ie licensing or buy-out offer from Merck.

Unfortunately in the meantime based on Corp presentation there is little else that might stimulate the current SP other than general biotech sentiment improvement.
Therefore as we approach multi-year lows I fear shorters will continue to manoeuvre the SP south.

Personally I'm done with accumulating IMM shares and averaging further down. Looks like it's up to you Joe!